These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8653889)

  • 1. Markers of activated coagulation and their usefulness in the clinical laboratory.
    Tripodi A; Mannucci PM
    Clin Chem; 1996 May; 42(5):664-9. PubMed ID: 8653889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms, markers and management of hypercoagulable states.
    Mannuci PM; Tripodi A
    Haemostasis; 1996 Oct; 26 Suppl 4():1-8. PubMed ID: 8979106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms, markers and management of coagulation activation.
    Mannucci PM
    Br Med Bull; 1994 Oct; 50(4):851-70. PubMed ID: 7804735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The investigation of a heart valve patient with suspected hypercoagulability.
    Gough SC; Prentice CR
    J Heart Valve Dis; 1993 Jan; 2(1):7-17. PubMed ID: 8269113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The overall hemostasis potential: a laboratory tool for the investigation of global hemostasis.
    Antovic A
    Semin Thromb Hemost; 2010 Oct; 36(7):772-9. PubMed ID: 20978998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of Hemostasis and Thrombosis and Contribution of Laboratory Testing to Diagnosis and Management of Hemostasis and Thrombosis Disorders.
    Bonar RA; Lippi G; Favaloro EJ
    Methods Mol Biol; 2017; 1646():3-27. PubMed ID: 28804815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of D-dimer in outpatients: clinical value and specific features].
    Vavilova TV; Vorob'eva IuK; Krupotkina IG; Mnuskina MM; Zherlitsina EA; Minkin SR
    Klin Lab Diagn; 2009 Nov; (11):42-6. PubMed ID: 20050285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of the prethrombotic state due to procoagulant imbalance.
    Mannucci PM; Giangrande PL
    Eur J Haematol; 1992 Feb; 48(2):65-9. PubMed ID: 1547877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.
    Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA
    Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory markers of coagulation activation.
    Bauer KA
    Arch Pathol Lab Med; 1993 Jan; 117(1):71-7. PubMed ID: 8418767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New markers for in vivo coagulation.
    Bauer KA
    Curr Opin Hematol; 1994 Sep; 1(5):341-6. PubMed ID: 9371303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in markers of coagulation and fibrinolysis in patients with Paroxysmal Nocturnal Hemoglobinuria before and during treatment with eculizumab.
    van Bijnen ST; Østerud B; Barteling W; Verbeek-Knobbe K; Willemsen M; van Heerde WL; Muus P
    Thromb Res; 2015 Aug; 136(2):274-81. PubMed ID: 26143713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation markers of coagulation.
    Bauer KA; Rosenberg RD
    Baillieres Clin Haematol; 1994 Sep; 7(3):523-40. PubMed ID: 7841599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The method of in vivo evaluation of hemostasis: Spatial thrombodynamics.
    Tuktamyshov R; Zhdanov R
    Hematology; 2015 Dec; 20(10):584-6. PubMed ID: 26067199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of anticoagulant therapy in cancer patients with thrombosis and the usefulness of blood activation markers.
    Amiral J; Seghatchian J
    Transfus Apher Sci; 2017 Jun; 56(3):279-286. PubMed ID: 28552490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interpretation of hemostatic and fibrinolytic markers].
    Asakura H
    Rinsho Byori; 2011 Oct; 59(10):970-7. PubMed ID: 22184880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
    Bombeli T; Raddatz-Mueller P; Fehr J
    Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of pituitary, adrenal, and parathyroid hormones on hemostasis and thrombosis.
    Squizzato A; Van Zaane B; Gerdes VE; Büller HR
    Semin Thromb Hemost; 2011 Feb; 37(1):41-8. PubMed ID: 21249603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices.
    Ganter MT; Hofer CK
    Anesth Analg; 2008 May; 106(5):1366-75. PubMed ID: 18420846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.